![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: GARS-DT |
Gene summary for GARS-DT |
![]() |
Gene information | Species | Human | Gene symbol | GARS-DT | Gene ID | 401320 |
Gene name | GARS1 divergent transcript | |
Gene Alias | GARS-DT | |
Cytomap | 7p14.3 | |
Gene Type | ncRNA | GO ID | NA | UniProtAcc | NA |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
401320 | GARS-DT | RNA-P17T-P17T-8 | Human | Lung | IAC | 4.12e-03 | 3.79e-01 | 0.3329 |
401320 | GARS-DT | RNA-P25T1-P25T1-4 | Human | Lung | AIS | 2.98e-05 | 3.39e-01 | -0.2119 |
401320 | GARS-DT | RNA-P3T-P3T-1 | Human | Lung | IAC | 1.17e-04 | 4.59e-01 | 0.1829 |
401320 | GARS-DT | RNA-P3T-P3T-2 | Human | Lung | IAC | 1.31e-02 | 3.76e-01 | 0.1835 |
401320 | GARS-DT | RNA-P3T-P3T-4 | Human | Lung | IAC | 8.54e-11 | 6.87e-01 | 0.1859 |
401320 | GARS-DT | RNA-P6T1-P6T1-1 | Human | Lung | MIAC | 3.00e-03 | 6.71e-01 | -0.0238 |
401320 | GARS-DT | RNA-P6T1-P6T1-3 | Human | Lung | MIAC | 9.90e-04 | 8.13e-01 | -0.0296 |
401320 | GARS-DT | RNA-P6T2-P6T2-1 | Human | Lung | IAC | 3.32e-17 | 5.20e-01 | -0.0166 |
401320 | GARS-DT | RNA-P6T2-P6T2-2 | Human | Lung | IAC | 1.34e-16 | 4.99e-01 | -0.0132 |
401320 | GARS-DT | RNA-P6T2-P6T2-3 | Human | Lung | IAC | 1.84e-18 | 5.22e-01 | -0.013 |
401320 | GARS-DT | RNA-P6T2-P6T2-4 | Human | Lung | IAC | 5.60e-14 | 4.80e-01 | -0.0121 |
401320 | GARS-DT | RNA-P7T1-P7T1-1 | Human | Lung | AIS | 3.94e-06 | 5.34e-01 | -0.0961 |
401320 | GARS-DT | RNA-P7T1-P7T1-2 | Human | Lung | AIS | 1.46e-05 | 4.38e-01 | -0.0876 |
401320 | GARS-DT | RNA-P7T1-P7T1-3 | Human | Lung | AIS | 1.74e-03 | 4.13e-01 | -0.0822 |
401320 | GARS-DT | HTA12-26-1 | Human | Pancreas | PDAC | 1.71e-17 | 8.28e-01 | 0.3728 |
401320 | GARS-DT | HTA12-29-1 | Human | Pancreas | PDAC | 5.44e-24 | 6.67e-01 | 0.3722 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Lung | ![]() | AAH: Atypical adenomatous hyperplasia |
AIS: Adenocarcinoma in situ | ||
IAC: Invasive lung adenocarcinoma | ||
MIA: Minimally invasive adenocarcinoma |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |